The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Apr. 19, 3:53 PM

Slide #7. TransEnterix Secondary Offering

Company: TransEnterix (AMEX:TRXC)
Date announced: 4/14/2014
Shares Offered: 12,500,000
Date of Pricing: 4/14/2014
Price Per Share: $4
Secondary Offering Details: TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced the pricing of its previously announced underwritten public offering of 12.5 million shares of its common stock at a public offering price of $4.00 per share for total gross proceeds of $50.0 million. TransEnterix has also granted the underwriters a 30-day option to purchase up to an additional 1.875 million shares of common stock to cover over-allotments, if any.

TransEnterix is a developmental stage medical device company focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. Co.'s products include: the AMID™ HFD stapler, which uses non-absorbable titanium staples to repair inguinal (groin) or ventral (abdominal) hernias; and SMART Dilator™, which is used when an endoscopy demonstrates the narrowing of the esophagus.
Open the TRXC Page at The Online Investor »

Company Name:  TransEnterix Inc
Sector:  Medical Instruments & Supplies

Open the TRXC Page at The Online Investor (in a new window) »

April 19, 2014    3:53 PM Eastern
Quotes delayed 20 minutes

Trade TRXC Now:

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.